There is a significant association between serum infliximab levels and rates of fistula healing. Achieving infliximab levels ≥10.1 mcg/mL in patients with Crohn's disease and perianal fistulas may improve outcomes as part of a treat-to-target strategy.
Brian Bressler, Gerassimos J. Mantzaris, Mark S. Silverberg, Petros Zezos, Dan Joseph Stein, Chris Colby, T Lissoos, C. Lopez, Athanasios Natsios, Gabriela Radulescu, Haridarshan Patel, Dirk Demuth, Andrés Yarur
Victòria Gudiño, Jae‐We Cho, Berta Caballol, A M Corraliza, Marisol Veny, Ángela Sanzo-Machuca, Lívia Moreira Genaro, E Melón-Ardanaz, Maria Carme Masamunt, Manel Esteller, A Fernández-Clotet, Íngrid Ordás, R Franco-Leal, Elena Ricart, Julián Panés, Martin Hemberg, Azucena Salas
Discussion(0)
No comments yet. Be the first to comment.